ONCOPEPTIDES AB financial statements, including revenue, expenses, profit, and loss

The total revenue of ONCO for the last quarter is 5.34 M SEK, and it's 90.27% higher compared to the previous quarter. The net income of Q4 23 is -81.21 M SEK.